Browsing by Author "Gerritsen, W.R."

Now showing items 1-50 of 83

The Oncology Data Network (ODN): A Collaborative European Data-Sharing Platform to Inform Cancer Care
Kerr, D.; Arnold, D.; Blay, J.Y.; Buske, C.; Carrato, A.; Gerritsen, W.R. ; Peeters, M.
2020, Article / Letter to editor (Oncologist, vol. 25, iss. 1, (2020), pp. e1-e4)
Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial
Privé, B.M. ; Janssen, M.J.R. ; Oort, I.M. van ; Muselaers, C.H.J.; Jonker, M.A. ; Groot, M. de ; Mehra, N. ; Verzijlbergen, J.F.; Scheenen, T.W.J. ; Zamecnik, P.; Barentsz, J.O. ; Gotthardt, M. ; Noordzij, W.; Vogel, W.V.; Bergman, A.M.; Poel, H.G. van der; Vis, Andre N.; Oprea-Lager, D.E.; Gerritsen, W.R. ; Witjes, J.A. ; Nagarajah, J. et al. sine al.
2020, Article / Letter to editor (BMC Cancer, vol. 20, iss. 1, (2020), article 884)
Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the Bladder
Wilpe, S. van ; Gerretsen, E.C.F.; Heijden, A.G. van der; Vries, I.J.M. de ; Gerritsen, W.R. ; Mehra, N.
2020, Article / Letter to editor (Cancers, vol. 12, iss. 9, (2020), article E2692)
A clinician's guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer
Veen, K.M.; Angst, I.B. de; Mokhles, M.Mostafa; Westgeest, H.M.; Kuppen, M.; Groot, C.A.R.; Gerritsen, W.R. ; Kil, P.J.; Takkenberg, J.J.
2020, Article / Letter to editor (Journal of Cancer Research and Clinical Oncology, vol. 146, iss. 8, (2020), pp. 2067-2075)
Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer
Doelen, M.J. van der ; Velho, Pedro Isaacsson; Slootbeek, P. H.J.; Naga, Samhita Pamidimarri; Bormann, Maren; Helvert, S. van ; Kroeze, L.; Oort, I.M. van ; Gerritsen, W.R. ; Antonarakis, Emmanuel S.; Mehra, N. et al. sine al.
2020, Article / Letter to editor (European Journal of Cancer, vol. 136, (2020), pp. 16-24)
Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination
Willigen, W.W. van; Bloemendal, M. ; Boers-Sonderen, M.J. ; Groot, J.W.B. de; Koornstra, R.H. ; Veldt, A.A.M. van der; Schreibelt, G. ; Gerritsen, W.R. ; Vries, I.J.M. de ; Bol, K.F.
2020, Article / Letter to editor (Oncoimmunology, vol. 9, iss. 1, (2020), article 1738814)
Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the Netherlands
Kuppen, Malou C.P.; Westgeest, Hans M.; Eertwegh, A.J. van den; Coenen, Jules L. L. M.; Moorselaar, R.J. van; Berg, P. van den; Mehra, N. ; Oort, I.M. van ; Gerritsen, W.R. ; Uyl-de Groot, Carin A.
2020, Article / Letter to editor (Clinical Genitourinary Cancer, vol. 18, iss. 3, (2020), pp. E233-E253)
Healthcare professionals' perspectives of barriers and facilitators in implementing physical activity programmes delivered to cancer survivors in a shared-care model: a qualitative study
Ijsbrandy, C. ; Harten, W.H. van; Gerritsen, W.R. ; Hermens, R.P.M.G. ; Ottevanger, P.B.
2020, Article / Letter to editor (Supportive Care in Cancer, vol. 28, iss. 7, (2020), pp. 3429-3440)
Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer
Kuppen, M.C.P.; Westgeest, H.M.; Doelen, M.J. van der ; Eertwegh, A.J. van den; Coenen, J.L.; Aben, K.K.H. ; Bergh, A.C. van den; Bergman, A.M.; Bosch, J. van den; Celik, F.; Hendriks, M.P; Lavalaye, J.; Meer, S.V.; Polee, M.B.; Somford, D.M.; Oort, I.M. van ; Uyl-de Groot, Carin A.; Gerritsen, W.R. et al. sine al.
2020, Article / Letter to editor (Future Oncology, vol. 16, iss. 19, (2020), pp. 1371-1384)
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors
Fizazi, K.; Drake, C.G.; Beer, T.M.; Kwon, Eugene D.; Scher, H.I.; Gerritsen, W.R. ; Chen, Allen; Logothetis, C.
2020, Article / Letter to editor (European Urology, vol. 78, iss. 6, (2020), pp. 822-830)
The Oncology Data Network (ODN): Methodology, Challenges, and Achievements
Woolmore, A.; Arnold, D.; Blay, J.Y.; Buske, C.; Carrato, A.; Gerritsen, W.R. ; Peeters, M.; Garcia-Foncillas, J.; Kerr, D.
2020, Article / Letter to editor (Oncologist, vol. 25, iss. 10, (2020), pp. e1428-e1432)
Lactate dehydrogenase: a marker of diminished antitumor immunity
Wilpe, S. van ; Koornstra, R.H. ; Brok, M. Den; Groot, J.W.B. de; Blank, C. ; Vries, J. de ; Gerritsen, W.R. ; Mehra, N.
2020, Article / Letter to editor (Oncoimmunology, vol. 9, iss. 1, (2020), article 1731942)
High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer
Westdorp, H.; Creemers, J.H.A.; Oort, I.M. van ; Mehra, N. ; Hins-de Bree, S.M.; Figdor, C.G. ; Witjes, J.A. ; Schreibelt, G. ; Vries, I.J.M. de ; Gerritsen, W.R. ; Ottevanger, P.B. et al. sine al.
2020, Article / Letter to editor (Frontiers in Oncology, vol. 10, (2020), article 536700)
Prior PSMA PET-CT Imaging and Hounsfield Unit Impact on Tumor Yield and Success of Molecular Analyses from Bone Biopsies in Metastatic Prostate Cancer
Smits, M. ; Ekici, K.; Pamidimarri Naga, S. ; Oort, I.M. van ; Sedelaar, M. ; Schalken, J.A. ; Nagarajah, J.; Scheenen, T.W.J. ; Gerritsen, W.R. ; Futterer, J.J. ; Mehra, N. et al. sine al.
2020, Article / Letter to editor (Cancers, vol. 12, iss. 12, (2020), article 3756)
Strong vaccine responses during chemotherapy are associated with prolonged cancer survival
Melief, Cornelis J.M.; Welters, Marij J.P.; Vergote, I.; Kroep, Judith R.; Kenter, Gemma G.; Ottevanger, P.B. ; Gerritsen, W.R. ; Burg, Sjoerd H. van der
2020, Article / Letter to editor (Science Translational Medicine, vol. 12, iss. 535, (2020), article eaaz8235)
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
Boudewijns, S; Bloemendal, M. ; Haas, N. de ; Westdorp, H.; Bol, K.F. ; Schreibelt, G. ; Aarntzen, E.H.J.G. ; Lesterhuis, W.J. ; Gorris, M.A.J.; Croockewit, A.J. ; Woude, L.L. van der ; Rossum, M.M. van ; Welzen, M.E. ; Goede, A.L. de ; Hato, S.V. ; Graaf, W.T.A. van der ; Punt, C.J.A. ; Koornstra, R.H. ; Gerritsen, W.R. ; Figdor, C.G. ; Vries, I.J.M. de et al. sine al.
2020, Article / Letter to editor (Cancer Immunology Immunotherapy, vol. 69, iss. 3, (2020), pp. 477-488)
Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study
Benoist, G.E. ; Oort, I.M. van ; Boerrigter, E. ; Verhaegh, G.W. ; Hooij, O. van ; Groen, L.N. ; Mehra, N. ; Gerritsen, W.R. ; Erp, N.P. van ; Schalken, J.A.
2020, Article / Letter to editor (Clinical Chemistry, vol. 66, iss. 6, (2020), pp. 842-851)
Implementing physical activity programs for patients with cancer in current practice: patients' experienced barriers and facilitators
Ijsbrandy, C. ; Hermens, R.P. ; Boerboom, L.W.M.; Gerritsen, W.R. ; Harten, W.H. van; Ottevanger, P.B.
2019, Article / Letter to editor (Journal of Cancer Survivorship, vol. 13, iss. 5, (2019), pp. 703-712)
A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics
Lubberman, F.J.E. ; Benoist, G.E. ; Gerritsen, W.R. ; Burger, D.M. ; Mehra, N. ; Hamberg, P.; Oort, I.M. van ; Erp, N. van
2019, Article / Letter to editor (Cancer Chemotherapy and Pharmacology, vol. 84, iss. 6, (2019), pp. 1179-1185)
Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands
Westgeest, H.M.; Kuppen, M.C.P.; Eertwegh, A.J. van den; Wit, R. de; Coenen, J.; Berg, H.Pieter van den; Mehra, N. ; Oort, I.M. van ; Fossion, L.; Hendriks, M.P; Bloemendal, H.J.; Luijtgaarden, A.C.M. van de; Huinink, D. Ten Bokkel; Bergh, A. von; Bosch, J; Polee, M.B.; Weijl, N.; Bergman, A.M.; Groot, C.A.R.; Gerritsen, W.R. et al. sine al.
2019, Article / Letter to editor (Clinical Genitourinary Cancer, vol. 17, iss. 5, (2019), pp. e946-e956)
18F-FDG PET/CT of Multiorgan Sarcoid-Like Reaction During Anti-PD-1 Treatment for Melanoma
Willigen, W.W. van; Gerritsen, W.R. ; Aarntzen, E.H.J.G.
2019, Article / Letter to editor (Clinical Nuclear Medicine, vol. 44, iss. 11, (2019), pp. 905-906)
Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy
Bloemendal, M. ; Willigen, W.W. van; Bol, K.F. ; Boers-Sonderen, M.J. ; Bonenkamp, J.J. ; Werner, J.E.M.; Aarntzen, E.H. ; Koornstra, R.H. ; Groot, J.W.B. de; Vries, I.J.M. de ; Hoeven, J.J.M. van der ; Gerritsen, W.R. ; Wilt, J.H.W. de et al. sine al.
2019, Article / Letter to editor (Annals of Surgical Oncology, vol. 26, iss. 12, (2019), pp. 3945-3952)
Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane
Willemsen, A.E.C.A.B. ; Tol, Jolien; Erp, N.P. van ; Jonker, M.A. ; Boer, Maaike de; Meek, Bob; Gerritsen, W.R. ; Grutters, Jan C.; Herpen, C.M.L. van
2019, Article / Letter to editor (Targeted Oncology, vol. 14, iss. 4, (2019), pp. 441-451)
Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer
Gulley, J.L.; Borre, M.; Vogelzang, N.J.; Ng, S.; Agarwal, N.; Parker, C.C.; Pook, D.W.; Rathenborg, P.; Flaig, T.W.; Carles, J.; Saad, F.; Shore, N.D.; Chen, L; Heery, C.R.; Gerritsen, W.R. ; Priou, F.; Langkilde, N.C.; Novikov, A.; Kantoff, P.W. et al. sine al.
2019, Article / Letter to editor (Journal of Clinical Oncology, vol. 37, iss. 13, (2019), pp. 1051-1061)
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of > 2 years of follow-up
Fradet, Y.; Bellmunt, J.; Vaughn, D.J.; Lee, J.L.; Fong, L.; Vogelzang, N.J.; Gerritsen, W.R. ; Wit, R. de; Bajorin, D.F.
2019, Article / Letter to editor (Annals of Oncology, vol. 30, iss. 6, (2019), pp. 970-976)
Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy
Bloemendal, M. ; Rietveld, M.J.A.; Willigen, W.W. van; Gerritsen, W.R. ; Figdor, C.G. ; Bonenkamp, J.J. ; Westdorp, H.; Boudewijns, S; Koornstra, R.H. ; Adang, E.M.M. ; Schreibelt, G. ; Ottevanger, P.B. ; Vries, I.J.M. de ; Bol, K.F. et al. sine al.
2019, Article / Letter to editor (Clinical & Translational Oncology, vol. 21, iss. 6, (2019), pp. 774-780)
Advances in targeted alpha therapy for prostate cancer
Vincentis, G. De; Gerritsen, W.R. ; Gschwend, J.E.; Hacker, M.; Lewington, V.; O'Sullivan, J.M.; Oya, M.; Pacilio, M.; Parker, C.; Shore, N.; Sartor, O. et al. sine al.
2019, Article / Letter to editor (Annals of Oncology, vol. 30, iss. 11, (2019), pp. 1728-1739)
Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer
Westdorp, H.; Creemers, J.H.A.; Oort, I.M. van ; Schreibelt, G. ; Gorris, M.A.J.; Mehra, N. ; Simons, M. ; Goede, A.L. de ; Rossum, M.M. van ; Croockewit, A.J. ; Figdor, C.G. ; Witjes, J.A. ; Aarntzen, E.H.J.G. ; Mus, R.D.M. ; Bruning, M.; Petry, K.; Gotthardt, M. ; Barentsz, J.O. ; Vries, I.J.M. de ; Gerritsen, W.R. et al. sine al.
2019, Article / Letter to editor (Journal for Immunotherapy of Cancer, vol. 7, iss. 1, (2019), pp. 302)
Patient Selection for Radium-223 Therapy in Patients With Bone Metastatic Castration-Resistant Prostate Cancer: New Recommendations and Future Perspectives
Doelen, M.J. van der ; Mehra, N. ; Hermsen, Rick; Janssen, M.J.R. ; Gerritsen, W.R. ; Oort, I.M. van
2019, Article / Letter to editor (Clinical Genitourinary Cancer, vol. 17, iss. 2, (2019), pp. 79-87)
Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time
Willigen, W.W. van; Bloemendal, M. ; Gerritsen, W.R. ; Schreibelt, G. ; Vries, I.J.M. de ; Bol, K.F.
2018, Article / Letter to editor (Frontiers in Immunology, vol. 9, (2018), article 2265)
Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer Registry
Westgeest, H.M.; Groot, C.A.R.; Moorselaar, R.J. van; Wit, R. de; Bergh, A.C. van den; Coenen, J.; Beerlage, H.P.; Hendriks, M.P; Bos, M.; Berg, P. van den; Wouw, A.J. van de; Spermon, R.; Boerma, M.O.; Geenen, M.M.; Tick, L.W.; Polee, M.B.; Bloemendal, H.J.; Cordia, I.; Peters, F.P.; Vos, A.I. de; Bosch, J; Eertwegh, A.J. van den; Gerritsen, W.R. et al. sine al.
2018, Article / Letter to editor (European Urology Focus, vol. 4, iss. 5, (2018), pp. 694-701)
A randomised phase II trial of docetaxel versus docetaxel plus carboplatin in patients with castration-resistant prostate cancer who have progressed after response to prior docetaxel chemotherapy: The RECARDO trial
Bouman-Wammes, Esther W.; Berg, H.Pieter van den; Munck, Linda de; Beeker, Aart; Smorenburg, Carolien H.; Vervenne, Walter L.; Gerritsen, W.R. ; Eertwegh, A.J. van den
2018, Article / Letter to editor (European Journal of Cancer, vol. 90, (2018), pp. 1-9)
223Ra Therapy in Patients With Advanced Castration-Resistant Prostate Cancer With Bone Metastases: Lessons from Daily Practice
Doelen, M.J. van der ; Kuppen, Malou C.P.; Jonker, M.A. ; Mehra, N. ; Janssen, M.J.R. ; Oort, I.M. van ; Gerritsen, W.R.
2018, Article / Letter to editor (Clinical Nuclear Medicine, vol. 43, iss. 1, (2018), pp. 9-16)
Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer
Vaughn, David J.; Bellmunt, Joaquim; Fradet, Yves; Lee, Jae Lyun; Fong, Lawrence; Vogelzang, Nicholas J.; Gerritsen, W.R. ; Bajorin, Dean F.; Wit, R. de
2018, Article / Letter to editor (Journal of Clinical Oncology, vol. 36, iss. 16, (2018), pp. 1579-+)
The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: a Retrospective Cohort Study
Knapen, Lotte M.; Koornstra, R.H. ; Driessen, Johanna H.M.; Vlijmen, B. van ; Croes, Sander; Schalkwijk, S.J.; Colbers, A. ; Gerritsen, W.R. ; Burger, D.M. ; Vries, Frank de; Erp, N.P. van et al. sine al.
2018, Article / Letter to editor (Targeted Oncology, vol. 13, iss. 3, (2018), pp. 363-370)
Review: Effectiveness of implementation strategies to increase physical activity uptake during and after cancer treatment
Ijsbrandy, C. ; Ottevanger, P.B. ; Diogeni, M.T.; Gerritsen, W.R. ; Harten, W.H. van; Hermens, R.P.M.G.
2018, Article / Letter to editor (Critical Reviews in Oncology Hematology, vol. 122, (2018), pp. 157-163)
Difficulties in Pain Management Using Oxycodone and Fentanyl in Enzalutamide-Treated Patients With Advanced Prostate Cancer
Westdorp, H.; Kuip, E.J.M. ; Oort, I.M. van ; Kramers, C. ; Gerritsen, W.R. ; Vissers, K.C.P.
2018, Article / Letter to editor (Journal of Pain and Symptom Management, vol. 55, iss. 4, (2018), pp. e6-e8)
Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane
Willemsen, A.E.C.A.B. ; Geus-Oei, L.F. de ; Boer, Maaike de; Tol, Jolien ; Kamm, Yvonne; Jong, P.C. de; Jonker, M.A. ; Aarntzen, E.H.J.G. ; Gerritsen, W.R. ; Herpen, C.M.L. van ; Erp, N.P. van et al. sine al.
2018, Article / Letter to editor (Targeted Oncology, vol. 13, iss. 5, (2018), pp. 641-648)
68Ga-PSMA Uptake in Angiolipoma
Dekker, I.; Leest, M.M. van der; Rijk, M.C. de; Gerritsen, W.R. ; Arens, A.I.J.
2018, Article / Letter to editor (Clinical Nuclear Medicine, vol. 43, iss. 10, (2018), pp. 757-758)
Now the dust has settled over immune checkpoint blockade in metastatic prostate cancer
Mehra, N. ; Gerritsen, W.R.
2018, Article / Letter to editor (Annals of Oncology, vol. 29, iss. 8, (2018), pp. 1620-1622)
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
Bellmunt, J.; Wit, R. de; Vaughn, D.J.; Fradet, Y.; Lee, J.L.; Fong, L.; Vogelzang, N.J.; Climent, M.A.; Petrylak, D.P.; Choueiri, T.K.; Necchi, A.; Gerritsen, W.R. ; Gurney, H.; Quinn, D.I.; Culine, S.; Sternberg, C.N. ; Mai, Y.; Poehlein, C.H.; Perini, R.F.; Bajorin, D.F. et al. sine al.
2017, Article / Letter to editor (The New England Journal of Medicine, vol. 376, iss. 11, (2017), pp. 1015-1026)
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma
Sznol, Mario; Ferrucci, Pier Francesco; Hogg, David; Atkins, Michael B.; Wolter, Pascal; Guidoboni, Massimo; Gerritsen, W.R. ; Hodi, F.Stephen; Wolchok, Jedd D.
2017, Article / Letter to editor (Journal of Clinical Oncology, vol. 35, iss. 34, (2017), pp. 3815-3822)
Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasma
Benoist, G.E. ; Meulen, E. van der ; Lubberman, F.J.E. ; Gerritsen, W.R. ; Smilde, T.J. ; Schalken, J.A. ; Beumer, J.H.; Burger, D.M. ; Erp, N. van
2017, Article / Letter to editor (Biomedical Chromatography, vol. 31, iss. 11, (2017), article e3986)
Molecular biomarkers to guide precision medicine in localized prostate cancer
Smits, M. ; Mehra, N. ; Sedelaar, M. ; Gerritsen, W.R. ; Schalken, J.A.
2017, Article / Letter to editor (Expert Review of Molecular Diagnostics, vol. 17, iss. 8, (2017), pp. 791-804)
Assessing Metastatic Disease in Advanced Prostate Cancer: It's Time to Change Imaging
Barentsz, J.O. ; Mulders, P.F.A. ; Gerritsen, W.R. ; Futterer, J.J.
2017, Article / Letter to editor (European Urology, vol. 71, iss. 1, (2017), pp. 93-95)
Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer
Beer, T.M.; Kwon, E.D.; Drake, C.G.; Fizazi, K.; Logothetis, C.; Gravis, G.; Ganju, V.; Polikoff, J.; Saad, F.; Humanski, P.; Piulats, J.M.; Mella, P. Gonzalez; Ng, S.S.; Jaeger, D.; Parnis, F.X.; Franke, F.A.; Puente, J.; Carvajal, R.; Sengelov, L.; McHenry, M.B.; Varma, A.; Eertwegh, A.J. van den; Gerritsen, W.R. et al. sine al.
2017, Article / Letter to editor (Journal of Clinical Oncology, vol. 35, iss. 1, (2017), pp. 40-47)
Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients
Wimmers, F.; Haas, N. de ; Scholzen, A.; Schreibelt, G. ; Simonetti, E.R. ; Eleveld, M.J. ; Brouwers, H.M.; Beldhuis-Valkis, M.; Joosten, I. ; Jonge, M.I. de ; Gerritsen, W.R. ; Vries, I.J.M. de ; Diavatopoulos, D.A. ; Jacobs, J.F.M. et al. sine al.
2017, Article / Letter to editor (Scientific Reports, vol. 7, (2017), article 43486)
Dendritic Cell-Based Immunotherapy: State of the Art and Beyond
Bol, K.F. ; Schreibelt, G. ; Gerritsen, W.R. ; Vries, I.J.M. de ; Figdor, C.G.
2016, Article / Letter to editor (Clinical Cancer Research, vol. 22, iss. 8, (2016), pp. 1897-1906)
Dendritic cell vaccination in melanoma patients: From promising results to future perspectives
Boudewijns, S; Bloemendal, M. ; Gerritsen, W.R. ; Vries, I.J.M. de ; Schreibelt, G.
2016, Article / Letter to editor (Human Vaccines & Immunotherapeutics, vol. 12, iss. 10, (2016), pp. 2523-2528)
Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination
Bol, K.F. ; Aarntzen, E.H. ; Hout, F.E. In 't ; Schreibelt, G. ; Creemers, J.H.; Lesterhuis, W.J. ; Gerritsen, W.R. ; Grunhagen, D.J.; Verhoef, C.; Punt, C.J. ; Bonenkamp, J.J. ; Wilt, J.H. de ; Figdor, C.G. ; Vries, I.J.M. de et al. sine al.
2016, Article / Letter to editor (Oncoimmunology, vol. 5, iss. 1, (2016), pp. e1057673)

Now showing items 1-50 of 83

Search Repository

Advanced Search

Browse

All of Repository

Radboud Repository

Browsing by Author "Gerritsen, W.R."

Search Repository

Browse

All of Repository